Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), the International Life Sciences Institute (ILSI) Research Foundation (RF), and the ILSI Health and Environmental Sciences Institute (HESI) hosted a workshop in November 2009 to review current practice in the application of mode of action (MOA) considerations in chemical risk assessment. The aim was to provide a rationale for a more general, but flexible approach and to propose steps to facilitate broader uptake and use of the MOA concept. There was consensus amongst the workshop participants that it will require substantial effort and cooperation from the multiple disciplines involved to embrace a common, consistent, and transparent approach. Setting up a repository of accepted MOAs and associated guidance concerning appropriate data to support specific MOAs for critical effects would facilitate categorization of chemicals and allow predictions of toxicity outcomes by read-across. This should in future contribute to the reduction of toxicity testing in animals. The workshop participants also acknowledged the value and importance of human data and the importance of integrating information from biological pathway analyses into current MOA/human relevance frameworks.

[1]  R. Maronpot,et al.  The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice , 2004, Cancer Research.

[2]  Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. , 2006, IARC monographs on the evaluation of carcinogenic risks to humans.

[3]  Ken Lunn,et al.  Managing the Process , 2003 .

[4]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[5]  Stephen W. Edwards,et al.  Systems biology and mode of action based risk assessment. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  P. Calow,et al.  Scientific Committee on Health and Environmental Risks opinion on: Risk Assessment Report on Vinyl acetate, Human Health Part , 2008 .

[7]  Vicki L Dellarco,et al.  A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  Gary M Williams,et al.  Application of mode-of-action considerations in human cancer risk assessment. , 2008, Toxicology letters.

[9]  E. Somers International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[10]  E. Lock,et al.  Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. , 1996, Toxicology and applied pharmacology.

[11]  J. Haines,et al.  International programme on chemical safety , 1996, The Lancet.

[12]  D Hattis,et al.  A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. , 2009, Critical reviews in toxicology.

[13]  J. Swenberg,et al.  Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  John C Lipscomb,et al.  Mode of action as a determining factor in additivity models for chemical mixture risk assessment. , 2007, Regulatory toxicology and pharmacology : RTP.

[15]  A. Boobis,et al.  The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.

[16]  Harmonization Project Document No . 2 CHEMICAL-SPECIFIC ADJUSTMENT FACTORS FOR INTERSPECIES DIFFERENCES AND HUMAN VARIABILITY : GUIDANCE DOCUMENT FOR USE OF DATA IN DOSE / CONCENTRATION – RESPONSE ASSESSMENT , 2005 .

[17]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[18]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[19]  Hoffmann Michael,et al.  Institute for Health and Consumer Protection Activity Report 2003 , 2004 .

[20]  D. Solís US Food and Drug Administration , 2010 .

[21]  J. Abraham The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .

[22]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[23]  M. Johnson,et al.  A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. , 1969, The Biochemical journal.

[24]  Division on Earth Risk Assessment in the Federal Government: Managing the Process , 1983 .

[25]  Frances E. Zollers,et al.  The European Food Safety Authority: Towards coherence in food safety policy and practice , 2004 .

[26]  Hyung-Sik Kang,et al.  Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. , 2006, Journal of proteome research.

[27]  J. Verhey,et al.  Risk assessment in the federal government , 1983 .

[28]  Jennifer Seed,et al.  Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.

[29]  C. Wolf,et al.  Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  J. G. Hengstler,et al.  Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH) , 2008, Archives of Toxicology.

[31]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[32]  Patricia A Stewart,et al.  Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: the National Cancer Institute Cohort. , 2009, Journal of the National Cancer Institute.

[33]  Shelly Puleo US Environmental Protection Agency , 1982 .

[34]  S. Eksborg,et al.  Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. , 2001, British journal of clinical pharmacology.

[35]  S. Hecht,et al.  Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. , 2009, Cancer research.

[36]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.

[37]  B. Butterworth,et al.  A classification framework and practical guidance for establishing a mode of action for chemical carcinogens. , 2006, Regulatory toxicology and pharmacology : RTP.

[38]  E. Lock,et al.  The role of mode of action studies in extrapolating to human risks in toxicology. , 2003, Toxicology Letters.

[39]  T. Carreón-Valencia Formaldehyde exposure and leukemia : a new meta-analysis and potential mechanisms , 2022 .

[40]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[41]  Marco Vighi,et al.  Scientific Committee on Health and Environmental Risks opinion on: Risk Assessment Report on 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYLCYCLOPENTA-γ-2-BENZOPYRAN (HHCB), Human Health Part, CAS No: 1222-05-5 EINECS No: 214-946-9 , 2008 .

[42]  B. Meek,et al.  Mode of Action Frameworks in Toxicity Testing and Chemical Risk Assessment , 2009 .

[43]  Mitchell S. Wilbanks,et al.  EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS , 2005 .

[44]  A. Elhajouji,et al.  Inhalation of formaldehyde does not induce systemic genotoxic effects in rats. , 2009, Mutation research.